ALOX5AP anticorps (C-Term)
Aperçu rapide pour ALOX5AP anticorps (C-Term) (ABIN374441)
Antigène
Voir toutes ALOX5AP AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Séquence
- C-KTISTTISPL LLIP
-
Specificité
-
This antibody recognizes the C-term of ALOX5AP.
Cellular Localization: Nucleus membrane. Endoplasmic reticulum membrane. -
Réactivité croisée (Details)
- Species reactivity (tested):Human.
-
Purification
- Ammonium Sulphate Precipitation followed by antigen Affinity Chromatography using the immunizing peptide.
-
Immunogène
- Peptide from the C Terminus of the protein sequence according to NP_001620. Genename: ALOX5AP
-
-
-
-
Indications d'application
-
Peptide ELISA: 1/32,000. Western Blot: 1 μg/mL. Detects a band of approx 48 kDa (predicted molecular weight: 18 kDa). An explanation has not been found for the difference in the two molecular weightvalues. This band was successfully blocked by incubation with the immunising peptide. Positive Control: Human Brain and U937 lysates.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.5 mg/mL
-
Buffer
- Tris saline, pH 7.3 containing 0.02 % Sodium Azide as preservative and 0.5 % BSA as stabilizer.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- ALOX5AP (Arachidonate 5-Lipoxygenase-Activating Protein (ALOX5AP))
-
Autre désignation
- ALOX5AP / FLAP
-
Sujet
- Genetic variations in ALOX5AP may be a cause of susceptibility to ischemic stroke (ISCHSTR) [MIM:601367], also known as cerebrovascular accident or cerebral infarction. A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. Ischemic strokes, resulting from vascular occlusion, is considered to be a highly complex disease consisting of a group of heterogeneous disorders with multiple genetic and environmental risk factors. Note=Genetic variations in ALOX5AP may be associated with susceptibility to myocardial infarction. Involvement in myocardial infarction is however unclear: according to some authors (PubMed:14770184), a 4-SNP haplotype in ALOX5AP confers risk of myocardial infarction, while according to other (PubMed:17304054) ALOX5AP is not implicated in this condition. Required for leukotriene biosynthesis by ALOX5 (5-lipoxygenase). Anchors ALOX5 to the membrane. Binds arachidonic acid, and could play an essential role in the transfer of arachidonic acid to ALOX5. Binds to MK-886, a compound that blocks the biosynthesis of leukotrienes.Synonyms: Arachidonate 5-lipoxygenase-activating protein, MK-886-binding protein
-
ID gène
- 241, 9606
-
UniProt
- P20292
Antigène
-